News
SHLT
2.050
0.00%
0.000
SHL Telemedicine publishes 2025 annual report
Reuters · 03/31 05:09
SHL Telemedicine files beneficial ownership Form 3 for officer Martin Bartetzko
Reuters · 03/30 15:18
SHL Telemedicine files initial beneficial ownership statement; director Orna Carni reports no securities owned
Reuters · 03/25 13:21
SHL Telemedicine files initial beneficial ownership statement; Director Yehoshua Abramovich reports 46,109 ordinary shares
Reuters · 03/25 13:16
SHL Telemedicine files initial beneficial ownership statement; CFO Lior Haalman reports options with CHF 3.25 and CHF 2.75 exercise prices
Reuters · 03/25 13:12
SHL Telemedicine Raises CHF 12.4 Million in Rights Offering and Capital Increase
Reuters · 12/03/2025 16:41
SHL Telemedicine Ltd. Held Shareholder Meeting
Reuters · 11/20/2025 17:00
SHL Telemedicine Proposes Authorized Share Capital Increase Ahead of Planned Rights Offering
Reuters · 10/30/2025 18:53
SHL Telemedicine Ltd. Held Special General Meeting of Shareholders
Reuters · 09/16/2025 16:01
SHL Telemedicine Ltd. Announces Date for Special General Meeting
Reuters · 08/12/2025 16:08
More
Webull provides a variety of real-time SHLT stock news. You can receive the latest news about SHL Telemed through multiple platforms. This information may help you make smarter investment decisions.
About SHLT
SHL Telemedicine Ltd (SHL) is an Israel-based company engaged in developing and marketing personal telemedicine solutions, with a focus on cardiovascular and related diseases. Personal telemedicine is the transmission of medical data by an individual, from a remote location, to a medical call center through telecommunication networks. SHL’s platform offers solutions to subscribing patients, health insurance companies, hospitals, clinics, physicians and other health care providers. Its solutions for healthcare professionals include: CHF monitoring service that supports patients suffering from Congestive Heart Failure; COPD monitoring service that supports patients suffering from Chronic Obstructive Pulmonary Disease, and Readmission Solutions for reducing heart-related readmissions. Its consumers' solutions include Cardiac Monitoring Service.